Search Results 1271-1280 of 21911 for Inhibition

1. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

   ... inhibitors; high potency or oral steroids). Known active human immunodeficiency virus (HIV) infection (defined as patients who are not on anti-retroviral ...

2. The Microenvironment In Barrett's Esophagus - Mayo Clinic

   Taking proton pump inhibitors at least once daily for 3 months prior to enrollment. Age ≥ 18 years old. Exclusion Criteria: History of gastric cancer. Any ...

3. Publications - Michael J. Santiago, M.D. - Mayo Clinic

   McKinley BJ, Santiago M, Pak C, Nguyen N, Zhong Q. Pneumatosis Intestinalis Induced by Alpha-Glucosidase Inhibitors in Patients with Diabetes Mellitus. J ...

4. Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer - Mayo Clinic

   ... inhibitor) =< 28 days prior to registration; Prior exposure to mitogen-activated protein kinase kinase (MEK), RAS, or RAF inhibitors (note: previous exposure ...

5. Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) - Mayo Clinic

   - Known significant bleeding sources other than nasal or gastrointestinal. - Systemic use of a potent VEGF inhibitor (e.g., direct inhibitors of VEGF-receptor

6. Macular Edema Ranibizumab V. Intravitreal Anti-inflammatory Therapy Trial - Mayo Clinic

   Use of oral acetazolamide or other systemic carbonic anhydrase inhibitor at baseline;; Known allergy or hypersensitivity to any component of the study drugs ...

7. Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough - Mayo Clinic

   Treatment with strong CYP3A4 inhibitors within 4 weeks prior to the Baseline Visit (Day 0); Treatment with any investigational therapy within 4 weeks ...

8. Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions - Mayo Clinic

   Taking any medications or herbal supplements that are known to be strong inhibitors of cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) =< 14 days ...

9. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

   ... inhibitor) if a fresh tumor biopsy is not feasible with an acceptable clinical risk; tumor lesions used for fresh biopsies should be the same lesions to be ...

10. Improve Graft Function and Reduce the Severity of Kidney Dysfunction or Delayed Graft Function Following Kidney Transplantation in Recipients of a Deceased Donor Kidney - Mayo Clinic

    Requires treatment with the cytochrome P450 (CYP) 1A2 inhibitors, ciprofloxacin and/or fluvoxamine (Luvox®). Unwilling or unable to comply with the protocol ...